Suppr超能文献

德克萨斯州顽固性疼痛治疗法案

The intractable pain treatment act of Texas.

作者信息

Hill C S

机构信息

Department of Neuro-Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030.

出版信息

Tex Med. 1992 Feb;88(2):70-2.

PMID:1348377
Abstract

There is overwhelming evidence that all types of pain, either of malignant or nonmalignant origin, are undertreated. This is especially true of patients whose pain can only be relieved by strong narcotics. The disciplinary section of the Texas Medical Practice Act (MPA) contains ambiguous language that makes determining proper standards for the use of narcotics difficult. To clarify this, the Intractable Pain Treatment Act (IPTA) allows the use of narcotics to treat intractable pain, without regard to the etiology of the pain, and clarifies narcotic use standards by defining intractable pain. The IPTA brings Texas law more into conformity with federal law, which clearly states that narcotics have a proper place in the treatment of intractable pain even if the etiology is not established. Reluctance to use narcotics for selected patients with nonmalignant painful medical conditions stems from the mistaken belief that they will become narcotic "addicts." Data from the medical literature do not support such a contention; in fact, just the opposite is supported.

摘要

有压倒性的证据表明,所有类型的疼痛,无论是恶性还是非恶性起源,都未得到充分治疗。对于那些疼痛只能通过强效麻醉药品缓解的患者来说尤其如此。《德克萨斯州医疗执业法》(MPA)的纪律部分包含模糊的措辞,使得确定麻醉药品的正确使用标准变得困难。为了澄清这一点,《顽固性疼痛治疗法》(IPTA)允许使用麻醉药品治疗顽固性疼痛,而不考虑疼痛的病因,并通过定义顽固性疼痛来明确麻醉药品的使用标准。《IPTA》使德克萨斯州的法律更符合联邦法律,联邦法律明确规定,即使病因未明,麻醉药品在顽固性疼痛的治疗中也有适当的地位。对于患有非恶性疼痛性疾病的特定患者,不愿使用麻醉药品源于一种错误的观念,即他们会成为麻醉药品“成瘾者”。医学文献中的数据并不支持这种观点;事实上,恰恰相反的观点得到了支持。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验